Cited by 107Endometriosis Research and TreatmentMenstrual Health and DisordersEctopic Pregnancy Diagnosis and Management

Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study

Open access
Ferrero, S., Camerini, G., Ragni, N., Venturini, P.L., Biscaldi, E., Remorgida, V.·2010·Human Reproduction

Abstract

BACKGROUND: This pilot study evaluates the efficacy of norethisterone acetate in treating pain and gastrointestinal symptoms of women with colorectal endometriosis. METHODS: This prospective study included 40 women with colorectal endometriosis, who had pain and gastrointestinal symptoms. Patients received norethisterone acetate (2.5 mg/day) for 12 months; in case of breakthrough bleeding, the dose of norethisterone acetate was increased by 2.5 mg/day. The degree of patient satisfaction with treatment (primary end-point) and the changes in symptoms (secondary end-point) were evaluated. Side effects of treatment were recorded. RESULTS: Norethisterone acetate determined a significant improvement in the intensity of chronic pelvic pain, deep dyspareunia, dyschezia. Treatment determined the disappearance of symptoms related to the menstrual cycle (dysmenorrhea, constipation during the menstrual cycle, diarrhoea during the menstrual cycle and cyclical rectal bleeding). The severity of diarrhoea, intestinal cramping and passage of mucus significantly improved during treatment. On the contrary, the administration of norethisterone acetate did not determine a significant effect on constipation, abdominal bloating and feeling of incomplete evacuation after bowel movements. At the completion of treatment, 57% of the patients with diarrhoea or diarrhoea during the menstrual cycle continued the treatment with norethisterone acetate compared with 17% of the patients with constipation or constipation during the menstrual cycle. CONCLUSIONS: In some patients with bowel endometriosis, the administration of norethisterone acetate may determine a relief of pain and gastrointestinal symptoms. This therapy has greater benefits in patients with gastrointestinal symptoms related to the menstrual cycle, diarrhoea and intestinal cramping.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/humrep/dep361

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a pilot study of women with bowel endometriosis, low-dose oral NETA significantly improved chronic pelvic pain, deep dyspareunia, dyschezia, and eliminated menstrual cycle-related symptoms.

    “A pilot study on women with bowel endometriosis showed that low dose oral NETA determined a significant improvement in the intensity of chronic pelvic pain, deep dyspareunia, dyschezia and the disappearance of symptoms related to the menstrual cycle (dysmenorrhea, constipation during the menstrual cycle, diarrhea during the menstrual cycle and cyclical rectal bleeding) [210].”
  • In a prospective case series of 40 women with bowel endometriosis, norethisterone acetate 2.5 mg/day for 12 months significantly improved dysmenorrhea, dyspareunia, chronic pelvic pain, dyschezia, and diarrhea.

    “Significant improvement of dysm, dysp, CPP, dyschezia and diarrhea.”
  • Numerous studies demonstrated efficacy of a reduced daily NETA dose of 2.5 mg.

    “numerous studies by independent groups demonstrated the efficacy of a reduced daily dose of 2.5 mg [13-16].”
  • In a pilot study of colorectal endometriosis, NETA 2.5 mg/d for 12 months achieved good satisfaction (60%) and more than half reported improvement in GI symptoms and amelioration of chronic pelvic pain and deep dyspareunia.

    “The satisfaction rate was good (60%), more than half of the patients reported an improvement in gastrointestinal symptoms and an amelioration of chronic pelvic pain and deep dyspareunia.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ferrero, S., Camerini, G., Ragni, N., Venturini, P. L., Biscaldi, E., & Remorgida, V.
Affiliations
  • Ospedale Policlinico San Martino (IT)
  • Istituto Giannina Gaslini (IT)
  • Ente Ospedaliero Ospedali Galliera (IT)
Venue
Human Reproduction
Published
2009-10-10
Volume
25
Issue
1
Pages
94-100
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2152713755
Cited by
107
References
38
Citations by year
2026: 4 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 2 · 2021: 5 · 2020: 13 · 2019: 3 · 2018: 11 · 2017: 8 · 2016: 10 · 2015: 9 · 2014: 5 · 2013: 4 · 2012: 4
FWCI
7.85
Type
journal article
Language
en
Open access
Locations
  • Human Reproduction (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
  • INFM-OAR (INFN Catania) (submittedVersion, other-oa)
  • Zenodo (CERN European Organization for Nuclear Research) (other-oa)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ectopic Pregnancy Diagnosis and Management
Keywords
norethisterone acetate, colorectal endometriosis, bowel endometriosis, chronic pelvic pain, dyschezia, dysmenorrhea, deep dyspareunia, treatment efficacy, patient satisfaction, adverse effects
MeSH terms
Norethindrone Acetate, Adult, Colonic Diseases, Endometriosis, Female, Humans, Norethindrone, Pain, Pilot Projects, Prospective Studies, Rectal Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review